Alpha Profiles · Executive Profile

Natarajan Sethuraman, Ph.D.

President of Research and Development at Entrada Therapeutics, Inc. (NASDAQ: TRDA)

https://registry.alpha.ac/people/natarajan-sethuraman-ph-d